Abstract
The coxsackie B viruses are a group of typical human enteroviruses (family Picornaviridae) that are comprised of six serotypes (CVB1-6). The CVBs are common etiologic agents of childhood disease including inflammatory diseases of the heart muscle and of the central nervous system and are the cause of a significant amount of adult inflammatory heart muscle disease (Martino et al. 1995). Dilated cardiomyopathy (DCM) has been linked to enterovirus infection of the heart through a variety of evidence, including serological data as well as molecular detection of viral RNA in diseased heart tissue samples (Keeling and Tracy 1995). A survey of results from a variety of studies suggest that, on average, about 20%–25% of DCM hearts show enteroviral involvement on the basis of polymerase chain reaction (PCR) or in situ hybridization data (Martino et al. 1995). Thus, many cases of both acute myocarditis as well as DCM may be considered as infectious viral diseases.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bergelson JM, Mohanty JG, Crowell RL, St. John NF, Lublin DM, Finberg RW (1995) Coxsackievirus B3 adapted to growth in RD cells binds to decay-accelerating factor (CD55). J Virol 69: 1903–1906
Caggana M, Chan P, Ramsingh A (1993) Identification of a single amino acid residue in the capsid protein VP1 of coxsackievirus B4 that determines the virulent phenotype. J Virol 67: 4797–4803
Chapman MS, Rossmann MG (1993) Comparison of surface properties of picornaviruses: strategies for hiding the receptor site from immune surveillance. Virology 195: 745–756
Chapman NM, Tu Z, Tracy S, Gauntt CJ (1994) An infectious cDNA copy of the genome of a non-cardiovirulent coxsackievirus B3 strain: its complete sequence analysis and comparison to the genomes of cardiovirulent coxsackieviruses. Arch Virol 135: 115–130
Chow LH, Beisel KW, McManus BM (1992) Enteroviral infection of mice with severe combined immunodeficiency. Evidence for direct viral pathogenesis of myocardial injury. Lab Invest 66: 24–31
de Verdugo UR, Selinka HC, Huber M, Kramer B, Kellerman J, Hofschnieder PH, Kandolf R (1995) Characterization of a 100-kilodalton binding protein for the six serotypes of Coxsackie B viruses. J Virol 69: 6751–6757
Gauntt CJ, Godeny EK, Lutton CW, Arizpe HM, Chapman NM, Tracy SM, Revtyak GE, Valente AJ, Rozek MM (1989) Mechanism(s) of coxsackievirus-induced acute myocarditis in the mouse. In: de la Maza, Peterson EM (eds) Medical virology 8. Plenum, New York, London, p 161
Huber SA, Polgar J, Schultheiss P, Schwimmbeck P (1994) Augmentation of pathogenesis of coxsackievirus B3 infections in mice by exogenous administration of interleukin-1 and interleukin-2. J Virol 68: 195–206
Keeling PJ, Tracy S (1995) Link between enteroviruses and dilated cardiomyopathy: serological and molecular data. Br Heart J 72: S25–25S29
Klump WM, Bergmann I, Muller BC, Ameis D, Kandolf R (1990) Complete nucleotide sequence of infectious Coxsackievirus B3 cDNA: two initial 5′ uridine residues are regained during plus-strand RNA synthesis. J Virol 64: 1573–1583
Le SY, Zuker M (1990) Common structures of the 5′ non-coding RNA in enteroviruses and rhinoviruses. Thermodynamical stability and statistical significance. J Mol Biol 216: 729–741
Leslie K, Blay R, Haisch C, Lodge A, Weller A, Huber S (1989) Clinical and experimental aspects of viral myocarditis. Clin Microbiol Rev 2: 191–203
Manolio TA, Baughman KL, Rodeheffer R, Pearson TA, Bristow JD, Michels VV, Abelmann WH, Harlan WR (1992) Prevalence and etiology of idiopathic dilated cardiomyopathy. Am J Cardiol 69: 1458–1466
Mapoles JE, Krah DL, Crowell RL (1985) Purification of a HeLa cell receptor protein for group B coxsackieviruses. J Virol 55: 560–566
Martin AB, Webber S, Fricker FJ, Jaffe R, Demmler G, Kearney D, Zhang YH, Bodurtha J, Gelb B, Ni J, Bricker JT, Towbin JA (1994) Acute myocarditis. Rapid diagnosis by PCR in children. Circulation 90: 330–339
Martino TA, Liu P, Pétric M, Sole MJ (1995) Enteroviral myocarditis and dilated cardiomyopathy: a review of clinical and experimental studies. In: Rotbart HA (ed) Human enterovirus infections. ASM, Washington D.C., p 291
Minor P (1993) Attenuation and reversion of the Sabin vaccine strains of poliovirus. Develop Biol Stand 78: 17–26
Muckelbauer JK, Kremer MK, Minor I, Diana G, Dutko FJ, Groarke J, Pevear DC, Rossmann MG (1995) The structure of coxsackievirus B3 at 3.5 Å resolution. Structure 3: 653–667
Tracy S, Chapman NM, Tu Z (1992) Coxsackievirus B3 from an infectious cDNA copy of the genome is cardiovirulent in mice. Arch Virol 122: 399–409
Tu Z, Chapman NM, Hufnagel G, Tracy S, Romero JR, Barry WH, Zhao L, Currey K, Shapiro B (1995) The cardiovirulent phenotype of coxsackievirus B3 is determined at a single site in the genomic 5′ nontranslated region. J Virol 69: 4607–4618
Zhang HY, Yousef GE, Cunningham L, Blake NW, OuYang X, Bayston TA, Kandolf R, Archard LC (1993) Attenuation of a reactivated cardiovirulent coxsackievirus B3: The 5′-non-translated region does not contain major attenuation determinants. J Med Virol 41: 129–137
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Chapman, N. et al. (1997). Coxsackievirus Genetics and the Cardiovirulent Viral Phenotype. In: Schultheiss, HP., Schwimmbeck, P. (eds) The Role of Immune Mechanisms in Cardiovascular Disease. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60463-8_3
Download citation
DOI: https://doi.org/10.1007/978-3-642-60463-8_3
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-61358-9
Online ISBN: 978-3-642-60463-8
eBook Packages: Springer Book Archive